Metagenomi Therapeutics Inc (MGX:NASDAQ)

$1.48 -0.13 (-8.07%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 48

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Metagenomi Therapeutics Inc (MGX:NASDAQ) News Sources

Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results

Yahoo Finance

external link

Metagenomi Therapeutics: Q4 Earnings Snapshot

Yahoo Finance

external link

Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Seeking Alpha

external link
MGX stock
MGX stock price
MGX stock price today
MGX stock prediction
MGX earnings date
MGX news
MGX price
MGX share
MGX share price
MGX shares
MGX ceo
MGX premarket
$MGX
MGX ticker
MGX after hours
MGX stock
MGX stock price
MGX stock price today
MGX stock prediction
MGX earnings date
MGX news
MGX price
MGX share
MGX share price
MGX shares
MGX ceo
MGX premarket
$MGX
MGX ticker
MGX after hours

Metagenomi Therapeutics Inc (MGX:NASDAQ) FAQs

toggle

What is the current price of Metagenomi Therapeutics Inc (MGX:NASDAQ)?

The current price of Metagenomi Therapeutics Inc (MGX:NASDAQ) is $1.48.


toggle

Metagenomi Therapeutics Inc (MGX:NASDAQ) absolute price change since previous trading day?

The absolute price change of Metagenomi Therapeutics Inc (MGX:NASDAQ) since the previous trading day is $-0.13.


toggle

Metagenomi Therapeutics Inc (MGX:NASDAQ) percentage price change since previous trading day?

The percentage price change of Metagenomi Therapeutics Inc (MGX:NASDAQ) since the previous trading day is -8.07%.


toggle

What is This Week's average sentiment score for Metagenomi Therapeutics Inc (MGX:NASDAQ)?

This Week's average sentiment score for Metagenomi Therapeutics Inc (MGX:NASDAQ) is 48 out of 100.


toggle

What is This Week's average sentiment for Metagenomi Therapeutics Inc (MGX:NASDAQ)?

This Week's sentiment for Metagenomi Therapeutics Inc (MGX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.